O.penVAPE Kicks Off Fundraising Project to Support Grow for Vets USA

 In Health, Medical Marijuana, PTSD

Multi-state effort begins with free cannabis oil for Vets on Veterans Day

DENVER, CO — (Marketwired – November 02, 2016) — O.penVAPE, the world’s largest cannabis consumer company, will kick off a program to benefit Grow for Vets USA, a national nonpartisan 501(c)(19) Colorado-based, nonprofit organization. The program will include participating dispensaries that will give away O.penVAPE cannabis oil to veterans on Veteran’s Day, Friday November 11th.

As a way of showing support for our veterans, O.penVAPE has pledged to donate one dollar from every O.penVAPE camouflage or American flag vaporizer sold online and in stores throughout its licensee network in Colorado, Oregon, New Mexico, Maine, Massachusetts and Nevada.

Roger Martin, executive director of Grow for Vets USA, said the charity provides veterans the resources and knowledge necessary to obtain or grow safer cannabis.

“Our organization works to help veterans ease their pain by providing easier access to medical cannabis, a more beneficial alternative to opioids,” Martin said. “We are very interested in promoting safer access to cannabis as well as a safer delivery system.”

Ralph Morgan, CEO of O.penVAPE, cited a March 2016 report from the Veteran’s Administration that concluded approximately 60 percent of returning soldiers from the Middle East and 50 percent of older generation veterans suffer from chronic pain. He referred to a 2013 analysis by the Center for Investigative Reporting that showed a 270 percent increase in written prescriptions for veterans for opiates over the past 12 years. The report concluded this spike led to heavy opioid addiction and a fatal overdose rate of two times the national average.

“Opioid dependence and abuse is a national tragedy and our vets are not at fault,” Morgan said. “We want to help veterans, our heroes, find a safer path to relief, free of opioids and the dangers associated with prolonged use of addictive drugs.”

Read more at marketwired.com